Sibrotuzumab

Tax included
Sibrotuzumab (BIBH 1) is a humanized IgG1 monoclonal antibody targets fibroblast activation protein (FAP). Sibrotuzumab can be used for the research of colorectal cancer and non-small cell lung cancer (NSCLC).
MedChemExpress 
HY-P99269

Data sheet

Size
Multiple sizes
Reactivity
FAP
Application
Cancer-programmed cell death
CAS
216669-97-5